Intravenous Immunoglobulin in the Treatment of Patient with Acute Disseminated Encephalomyelitis: Case Report
Journal Title: International Journal of Medical and Pharmaceutical Case Reports - Year 2015, Vol 5, Issue 5
Abstract
Background: Acute disseminated encephalomyelitis (ADEM) is a monophasic process nevertheless sometimes aggravated by relapses (so-called multiphase course of the disease). The treatment of ADEM must be targeted at reducing clinical manifestations of the disease and prevention of its relapses. Case Presentation: We report a 42-year old woman with a diagnosis of acute disseminated encephalomyelitis. The patient received intravenous immunoglobulin in the dose of 0.4 g per 1 kg of body mass within 5 days 1 month after the hormonal pulse-therapy. The treatment was followed by monthly administration of human normal immunoglobulin – 0.4 g per 1 kg of body mass within 24 months as a method of ADEM monotherapy. The positive dynamics of clinical symptoms was recorded 5 days after the beginning of the treatment (tendon anisoreflexia and swaying reduced). The treatment was followed by monthly administration of human normal immunoglobulin in the dose of 0.4 mg/kg. Three, nine and eighteen months after the beginning of the treatment the patient had two more MRI investigations of the brain that showed positive dynamics of the disease: reduction of demyelination foci and no accumulation of contrast agents. Her neurological deficits disappeared completely in 3 months. No relapses were observed over 24 months of observation. Conclusion: This case report confirms a positive therapeutic efficacy of intravenous immunoglobulin in the treatment of patient with ADEM – reduction of clinical manifestations of the disease, in particular a decrease in neurological deficit level. Monthly intravenous immunoglobulin administration also helps to prevent the disease relapses (multiphase ADEM course).
Authors and Affiliations
Iryna Lobanova
Keywords
Related Articles
- EP ID EP343673
- DOI 10.9734/IJMPCR/2015/19364
- Views 98
- Downloads 0
Bisphosphonate-Associated Bilateral Atraumatic Ulna Fractures
Aims: From 2003, low-impact fractures have been reported in association with bisphosphonate (BP) therapy. Most have involved the proximal femur, but over 100 cases involving other anatomic locations have been published....
Metoprolol-induced Psoriasiform Drug Eruption: A Case Report
Aim: We report the case of drug-induced psoriasiform eruptions in a middle aged known hypertensive and diabetic woman being treated for paroxysmal cardiac arrhythmias with metoprolol. Case Presentation: A 58-year-old kno...
Hidradenitis Suppurativa: Two-case Reports
Hidradenitis suppurativa (HS) is a common (though rarely diagnosed) disease affecting the apocrine glands. It is chronic in nature and mainly found in areas rich in apocrine glands like axillae, groins, under the breast,...
Treatment of Fibroepitheial Hyperplasia with PRF: An Interesting Outcome
Introduction: Gingival overgrowths in the oral cavity not only cause functional and esthetic problems but also increase the risk for the development of caries and periodontal disorders when left untreated. This article f...
Paradoxical Lymphadenopathy after Successful Treatment of Tuberculous Pleuritis
Tuberculous lymphadenopathy can paradoxically increase in size after initial clinical improvement. This paradoxical reaction during tuberculosis treatment is more common among HIV positive than non-HIV patients. However...